Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Raney Ni Catalyzed Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102234238B reveals a mild Raney-Ni catalyzed route for Agomelatine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Raney Ni catalyzed method for N-[2-(phenylmethyl)phenyl]-2-chloroacetamide. Reduces cost and pollution significantly. Reliable pharmaceutical intermediates supplier.